Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Pharmacology, PhD, A study of the cardiovascular actions of dopamine, University of Melbourne
Award Date: 2 Nov 1981
External positions
Baker Heart and Diabetes Institute
Research area keywords
- Endothelium
- Diabetes complication
- Vascular Disease
- Pulmonary Hypertension
- Flavonols
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 2 Finished
-
RESOLVING INFLAMMATION TO TREAT DIABETIC VASCULAR REMODELLING
Qin, C. H., Wright, K., Ritchie, R. & Woodman, O. L.
Diabetes Australia, Monash University – Internal Department Contribution
1/06/22 → 31/05/24
Project: Research
-
Exploiting Biased Agonists of Formyl Peptide Receptors as Pharmacotherapy for Pulmonary Hypertension: simultaneous targeting of vascular function and remodelling
Qin, C. H., Wright, K. & Woodman, O. L.
1/04/20 → 31/12/23
Project: Research
-
Biased receptor signalling and intracellular trafficking profiles of structurally distinct formylpeptide receptor 2 agonists
Peng, C., Vecchio, E. A., Nguyen, A. T. N., De Seram, M., Tang, R., Keov, P., Woodman, O. L., Chen, Y. C., Baell, J., May, L. T., Zhao, P., Ritchie, R. H. & Qin, C. X., Nov 2024, In: British Journal of Pharmacology. 181, 22, p. 4677-4692 16 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access1 Citation (Scopus) -
Formyl peptide receptor 1 mitigates colon inflammation and maintains mucosal homeostasis through the inhibition of CREB-C/EBPβ-S100a8 signaling
Li, T., Zhou, X., Zhang, Q., Miao, Q., Woodman, O. L., Chen, Y. & Qin, C., Aug 2024, In: Mucosal Immunology. 17, 4, p. 651-672 22 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Novel formylpeptide receptor 1/2 agonist limits hypertension-induced cardiovascular damage
Singh, J., Jackson, K. L., Fang, H., Gumanti, A., Claridge, B., Tang, F. S., Kiriazis, H., Salimova, E., Parker, A. M., Nowell, C., Woodman, O. L., Greening, D. W., Ritchie, R. H., Head, G. A. & Qin, C. X., 1 Jul 2024, In: Cardiovascular Research. 120, 11, p. 1336-1350 15 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access2 Citations (Scopus) -
The pro-resolving mediator, annexin A1 regulates blood pressure, and age-associated changes in cardiovascular function and remodeling
Singh, J., Jackson, K. L., Tang, F. S., Fu, T., Nowell, C., Salimova, E., Kiriazis, H., Ritchie, R. H., Head, G. A., Woodman, O. L. & Qin, C. X., 15 Feb 2024, In: The FASEB Journal. 38, 3, 19 p., e23457.Research output: Contribution to journal › Article › Research › peer-review
Open Access3 Citations (Scopus) -
The small-molecule formyl peptide receptor biased agonist, compound 17b, is a vasodilator and anti-inflammatory in mouse precision-cut lung slices
Studley, W. R., Lamanna, E., Martin, K. A., Nold-Petry, C. A., Royce, S. G., Woodman, O. L., Ritchie, R. H., Qin, C. X. & Bourke, J. E., Jul 2024, In: British Journal of Pharmacology. 181, 14, p. 2287-2301 15 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access2 Citations (Scopus)